Soliris | search
Click here to view Soliris news from 60+ newspapers.
Bookmark or Share- Getting Started | SOLIRIS® (eculizumab)SOLIRIS is a medicine that affects your immune system and may lower the ability of your immune system to fight infections. SOLIRIS increases your chance of getting serious meningococcal infections that may quickly become life-threatening or cause death if not recognized and treated early.
- Soliris® (eculizumab) | AlexionSOLIRIS and NMOSD. SOLIRIS is the first and only complement inhibitor approved by the FDA for the treatment of adults with anti-aquaporin-4 (AQP4) antibody-positive neuromyelitis optica spectrum disorder (NMOSD). 1. SOLIRIS is the first and only FDA-approved drug for the treatment of NMOSD in adult patients who are anti-AQP4 antibody positive.
- SOLIRIS® (eculizumab) Home | HCP SiteSOLIRIS® (eculizumab) is used to treat patients with NMOSD. Please see Important Safety Information, including Boxed Warning, and Medication Guide.
- Soliris (Eculizumab): Side Effects, Uses, Dosage, Interactions ... - RxListSOLIRIS is a medicine that affects your immune system. SOLIRIS may lower the ability of your immune system to fight infections. SOLIRIS increases your chance of getting serious meningococcal infections caused by Neisseria meningitidis bacteria.
- SOLIRIS® (eculizumab) HCP | DosingDosing regimen for adult patients with anti-AQP4 antibody-positive NMOSD 1. Administer SOLIRIS ® (eculizumab) over 35 minutes at the recommended dosage regimen time points, or within 2 days of these time points. If an adverse reaction occurs during the administration of SOLIRIS, the infusion may be slowed or stopped at the discretion of the ...
More
